Editas Medicine (EDIT) FCF Margin Growth (1y) (2016 - 2025)
Editas Medicine (EDIT) FCF Margin Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8.67 Mn |
| Jun 30, 2025 | 942,960.00 |
| Mar 31, 2025 | 346,905.00 |
| Dec 31, 2024 | -11,752.00 |
| Sep 30, 2024 | -8.65 Mn |
| Jun 30, 2024 | -946,278.00 |
| Mar 31, 2024 | -409,490.00 |
| Dec 31, 2023 | 57,971.00 |
| Sep 30, 2023 | 11.43 Mn |
| Jun 30, 2023 | -83,730.00 |
| Mar 31, 2023 | 38,191.00 |
| Dec 31, 2022 | -33,902.00 |
| Sep 30, 2022 | -11.43 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 829.00 |
| Dec 31, 2021 | 12,833.00 |
| Sep 30, 2021 | -55,870.00 |
| Jun 30, 2021 | -1.06 Mn |
| Mar 31, 2021 | 21,415.00 |
| Dec 31, 2020 | -77,620.00 |